Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01458509 · ClinicalTrials.gov registry record

Feasibility and Psychometric Properties of Paper vs. Web vs. Automated Telephone Administration of Patient Reported Outcome Surveys

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
325
Enrollment target

NCT01458509: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT01458509 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 325 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01458509 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
325 participants
Enrollment target

Study Summary

It can be difficult to obtain the perspective of patients who have had bowel surgery. This study is being done because the investigators are trying to find out whether patient-reported outcomes, (results reported to investigators by the patient), on a regular basis, will help the investigators provide better patient care and symptom management. Therefore, the purpose of this study is to determine if it is possible and if it is useful to their medical care for patients who have had bowel surgery to complete surveys about their symptoms on a regular basis. In this study the surveys are completed from home, by web or by telephone, every month for 6 months. The results of this study will guide the design of large research studies on cancer-related bowel function. The purpose of this study is to develop a bowel function questionnaire for patients with colorectal cancer. The questionnaire will be used in future clinical trials to assess bowel function.

Primary Outcome

using electronic methods (interactive voice response system (IVRS) or web interface)

Interventions

  • BEHAVIORAL surveys
  • BEHAVIORAL Surveys

Trial Details

FieldValue
Enrollment Target 325 participants
Start Date 2011-10-11
Est. Completion 2021-09-08
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT01458509 record still lists

NCT01458509 is an observational study that tracks outcomes without assigning an intervention. The registered 325 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 2 interventions - of which surveys is the first listed.

NCT01458509 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01458509 about?

NCT01458509 is a clinical study titled "Feasibility and Psychometric Properties of Paper vs. Web vs. Automated Telephone Administration of Patient Reported Outcome Surveys". It can be difficult to obtain the perspective of patients who have had bowel surgery. This study is being done because the investigators are trying to find out whether patient-reported outcomes, (results reported to investigators by the patient), on a regular basis, will help the investigators provi...

What is the current status of trial NCT01458509?

This trial is currently completed. The enrollment target is 325 participants. The study started on 2011-10-11. Estimated completion is 2021-09-08.

What interventions are being tested in trial NCT01458509?

The interventions under investigation include: surveys (BEHAVIORAL), Surveys (BEHAVIORAL).

Who is sponsoring clinical trial NCT01458509?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02543983 · 325 participants · Phase 2

    Neurobiology of Suicide

  • NCT03016819 · 325 participants · Phase 3

    Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

  • NCT03288207 · 325 participants · NA

    Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments

  • NCT04986657 · 325 participants · NA

    Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01458509, the US trial registry maintained by the National Library of Medicine. NCT01458509 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.